These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4291816)

  • 1. Isolation from Bordetella pertussis of protective antigen free from toxic activity and histamine sensitizing factor.
    Nagel J
    Nature; 1967 Apr; 214(5083):96-7. PubMed ID: 4291816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 3. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.
    Munoz J; Hestekin BM
    J Bacteriol; 1966 Jun; 91(6):2175-9. PubMed ID: 4287581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative characteristics of the toxic properties of the whooping cough microbes].
    Chuprinina RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):111-6. PubMed ID: 173120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic factors of Bordetella pertussis, with special reference to leukocytosis-promoting factor, histamine-sensitizing factor and hemagglutinins (author's transl)].
    Sato Y
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():164-83. PubMed ID: 194282
    [No Abstract]   [Full Text] [Related]  

  • 8. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent segregation of the H-2 locus and the locus for responsiveness to histamine-sensitizing factor.
    Ovary Z; Vris TW; de Szalay C; Vaz NM; Iritani CA
    Proc Natl Acad Sci U S A; 1973 Sep; 70(9):2500-1. PubMed ID: 4354853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and toxicity of soluble trichloroacetic acid precipitate from pertussis microbes and its fractions].
    Bazhanova IG; Gladkaia VI; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):128-32. PubMed ID: 202117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 14. The reactivity of mice after hyperimmunization with Bordetella pertussis.
    David C; Pozsgi N; Andreescu V; Caffé I
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):313-8. PubMed ID: 4377531
    [No Abstract]   [Full Text] [Related]  

  • 15. The stability of the protective antigen and histamine-sensitizing factor of Bordetella pertussis to acid and alkali.
    Jakus CM; McClure L; Wardlaw AC
    Can J Microbiol; 1968 Feb; 14(2):147-51. PubMed ID: 4296232
    [No Abstract]   [Full Text] [Related]  

  • 16. [PASSIVE PROTECTION AGAINST HYPOTHERMIA IN ASSAY OF THE ANTI-HISTAMINE-SENSITIZING POTENCY OF ANTI-BORDETELLA PERTUSSIS SERUM].
    GUERAULT A; QUEVILLON M
    Rev Can Biol; 1964 Dec; 23():485-7. PubMed ID: 14257897
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis.
    Lehrer SB; Vaughan JH; Tan EM
    J Immunol; 1975 Jan; 114(1 Pt 1):34-9. PubMed ID: 46244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the mouse model for study of encephalopathy in pertussis vaccine recipients.
    Hewlett EL; Cowell JL
    Infect Immun; 1989 Mar; 57(3):661-3. PubMed ID: 2537253
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity testing of pertussis vaccines: effect of increased sensitivity of mice to Bordetella pertussis.
    Cameron J; Desormeaux Y; De Bellefeuille ML; Leclerc J
    J Biol Stand; 1984 Jan; 12(1):19-24. PubMed ID: 6321509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.